Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Effects of indoor particulate matter exposure on daily asthma control.

Hussain S, Parker S, Edwards K, Finch J, Jeanjean A, Leigh R, Gonem S.

Ann Allergy Asthma Immunol. 2019 Oct;123(4):375-380.e3. doi: 10.1016/j.anai.2019.07.020. Epub 2019 Jul 26.

PMID:
31351980
2.

Artificial intelligence for pulmonary function test interpretation.

Gonem S, Siddiqui S.

Eur Respir J. 2019 Jun 5;53(6). pii: 1900638. doi: 10.1183/13993003.00638-2019. Print 2019 Jun. No abstract available.

PMID:
31167884
3.

DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment.

Saunders R, Kaul H, Berair R, Gonem S, Singapuri A, Sutcliffe AJ, Chachi L, Biddle MS, Kaur D, Bourne M, Pavord ID, Wardlaw AJ, Siddiqui SH, Kay RA, Brook BS, Smallwood RH, Brightling CE.

Sci Transl Med. 2019 Feb 13;11(479). pii: eaao6451. doi: 10.1126/scitranslmed.aao6451.

4.

Asthma admission rates and patterns of salbutamol and inhaled corticosteroid prescribing in England from 2013 to 2017.

Gonem S, Cumella A, Richardson M.

Thorax. 2019 Jul;74(7):705-706. doi: 10.1136/thoraxjnl-2018-212723. Epub 2019 Jan 10.

PMID:
30630892
5.

Modelling the effect of gravity on inert-gas washout outputs.

Foy BH, Gonem S, Brightling C, Siddiqui S, Kay D.

Physiol Rep. 2018 May;6(10):e13709. doi: 10.14814/phy2.13709.

6.

Effects of personal air pollution exposure on asthma symptoms, lung function and airway inflammation.

Chambers L, Finch J, Edwards K, Jeanjean A, Leigh R, Gonem S.

Clin Exp Allergy. 2018 Jul;48(7):798-805. doi: 10.1111/cea.13130. Epub 2018 Apr 10.

PMID:
29526044
7.

Associations in asthma between quantitative computed tomography and bronchial biopsy-derived airway remodelling.

Berair R, Hartley R, Mistry V, Sheshadri A, Gupta S, Singapuri A, Gonem S, Marshall RP, Sousa AR, Shikotra A, Kay R, Wardlaw A, Bradding P, Siddiqui S, Castro M, Brightling CE.

Eur Respir J. 2017 May 1;49(5). pii: 1601507. doi: 10.1183/13993003.01507-2016. Print 2017 May.

8.

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.

Gonem S, Berair R, Singapuri A, Hartley R, Laurencin MFM, Bacher G, Holzhauer B, Bourne M, Mistry V, Pavord ID, Mansur AH, Wardlaw AJ, Siddiqui SH, Kay RA, Brightling CE.

Lancet Respir Med. 2016 Sep;4(9):699-707. doi: 10.1016/S2213-2600(16)30179-5. Epub 2016 Aug 5.

PMID:
27503237
9.

Domiciliary exhaled nitric oxide and eosinophilic airway inflammation in adults with asthma.

Nanda CR, Singapuri A, Soares M, Monteiro W, Siddiqui S, Gonem S.

Eur Respir J. 2016 Jul;48(1):242-4. doi: 10.1183/13993003.02060-2015. Epub 2016 Apr 21. No abstract available.

10.

Characterization of acinar airspace involvement in asthmatic patients by using inert gas washout and hyperpolarized (3)helium magnetic resonance.

Gonem S, Hardy S, Buhl N, Hartley R, Soares M, Kay R, Costanza R, Gustafsson P, Brightling CE, Owers-Bradley J, Siddiqui S.

J Allergy Clin Immunol. 2016 Feb;137(2):417-25. doi: 10.1016/j.jaci.2015.06.027. Epub 2015 Aug 1.

PMID:
26242298
11.

Lung clearance index in adults with non-cystic fibrosis bronchiectasis.

Gonem S, Scadding A, Soares M, Singapuri A, Gustafsson P, Ohri C, Range S, Brightling CE, Pavord I, Horsley A, Siddiqui S.

Respir Res. 2014 May 18;15:59. doi: 10.1186/1465-9921-15-59.

12.

Between-visit variability of small airway obstruction markers in patients with asthma.

Gonem S, Corkill S, Singapuri A, Gustafsson P, Costanza R, Brightling CE, Siddiqui S.

Eur Respir J. 2014 Jul;44(1):242-4. doi: 10.1183/09031936.00001814. Epub 2014 Mar 6. No abstract available.

13.

Validation of a photoacoustic gas analyser for the measurement of functional residual capacity using multiple-breath inert gas washout.

Gonem S, Singer F, Corkill S, Singapuri A, Siddiqui S, Gustafsson P.

Respiration. 2014;87(6):462-8. doi: 10.1159/000357786. Epub 2014 Feb 13.

14.

Clinical significance of small airway obstruction markers in patients with asthma.

Gonem S, Natarajan S, Desai D, Corkill S, Singapuri A, Bradding P, Gustafsson P, Costanza R, Kajekar R, Parmar H, Brightling CE, Siddiqui S.

Clin Exp Allergy. 2014 Apr;44(4):499-507. doi: 10.1111/cea.12257.

PMID:
24341600
15.

Phenotyping airways disease: an A to E approach.

Gonem S, Raj V, Wardlaw AJ, Pavord ID, Green R, Siddiqui S.

Clin Exp Allergy. 2012 Dec;42(12):1664-83. doi: 10.1111/j.1365-2222.2012.04008.x. Review.

PMID:
23181785
16.

Advances in the management of severe asthma.

Siddiqui S, Gonem S, Wardlaw AJ.

Semin Respir Crit Care Med. 2012 Dec;33(6):666-84. doi: 10.1055/s-0032-1326964. Epub 2012 Oct 9.

PMID:
23047316
17.

Airway impedance entropy and exacerbations in severe asthma.

Gonem S, Umar I, Burke D, Desai D, Corkill S, Owers-Bradley J, Brightling CE, Siddiqui S.

Eur Respir J. 2012 Nov;40(5):1156-63. doi: 10.1183/09031936.00228611. Epub 2012 Mar 9.

18.

Lung damage and airway remodelling in severe asthma.

Brightling CE, Gupta S, Gonem S, Siddiqui S.

Clin Exp Allergy. 2012 May;42(5):638-49. doi: 10.1111/j.1365-2222.2011.03917.x. Epub 2011 Dec 22. Review.

PMID:
22192725
19.

Evidence for phenotype-driven treatment in asthmatic patients.

Gonem S, Desai D, Siddiqui S, Brightling CC.

Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):381-5. doi: 10.1097/ACI.0b013e328348a8f9. Review.

PMID:
21670666

Supplemental Content

Support Center